<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04348162</url>
  </required_header>
  <id_info>
    <org_study_id>AGL2016-76832-R</org_study_id>
    <nct_id>NCT04348162</nct_id>
  </id_info>
  <brief_title>Food Anthocyanins and Flavanols as a Strategy for a Healthy Ageing: Cardiovascular Health and Cognitive Performance</brief_title>
  <acronym>POLYAGE</acronym>
  <official_title>Food Anthocyanins and Flavanols as a Strategy for a Healthy Ageing: Cardiovascular Health and Cognitive Performance</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>National Research Council, Spain</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Hospital Universitario 12 de Octubre</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>National Research Council, Spain</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study examines the effect of cocoa flavanols, red-berries anthocyanins or a combination
      of both on markers of cardiovascular health and cognition.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The study examines the effect of cocoa flavanols, red-berries anthocyanins or a combination
      of both on markers of cardiovascular health and cognition.

      Healthy volunteers are recruited to participate in a parallel study (n 30 per group) for 10
      to 12 weeks. Markers of cardiovascular health (FMD, markers of inflammation and fatty acid
      metabolism) and cognition (neuropsychological tests and plasma neurotrophins) are being
      measured before and after intervention.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 15, 2017</start_date>
  <completion_date type="Anticipated">December 1, 2020</completion_date>
  <primary_completion_date type="Anticipated">May 15, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double (Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change from baseline of flow-mediated vasodilatation (FMD) of the brachial artery</measure>
    <time_frame>Over 6 minutes on day 0 and after10 weeks</time_frame>
    <description>The FMD of the brachial artery will be measured using an ultrasound collected at baseline and continuously for 60 seconds post-arm occlusion for 5 minutes. FMD will be expressed as percentage of variation between pre-and postischemic diameters</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change from baseline STROOP score after 10 weeks intervention</measure>
    <time_frame>at inclusion and 10 weeks after intervention</time_frame>
    <description>STROOP tests attention and executive function. This test aims to evaluate the inhibition of an automated process such as reading by asking participants to name the color of color names written in a different color ink.
For each participant SROOP results at inclusion will be compared with results after 10 weeks intervention</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from baseline Tower of London score after 10 weeks intervention</measure>
    <time_frame>at inclusion and 10 weeks after intervention</time_frame>
    <description>Tower of London test consist of a three color game board that allows executive functioning evaluation by total time, time to first move and optimal moves change from participants inclusion to week 11.</description>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">90</enrollment>
  <condition>Healthy Aging</condition>
  <arm_group>
    <arm_group_label>Cocoa Flavanols</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Cocoa is taken every day for 10-12 weeks.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Berries anthocyanins</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Red-berries are taken every day for 10-12 weeks.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Cocoa flavanols plus berries anthocyanins</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Cooa and red-berries are taken every day for 10-12 weeks.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Normal diet for 10-12 weeks</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Cocoa flavanols and berries anthocyanins</intervention_name>
    <description>Effect of cocoa flavanols and berries anthocyanins on cardiovascular and cognitive health</description>
    <arm_group_label>Berries anthocyanins</arm_group_label>
    <arm_group_label>Cocoa Flavanols</arm_group_label>
    <arm_group_label>Cocoa flavanols plus berries anthocyanins</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age 50-85

          -  BMI 20-32 Kg/m2

        Exclusion Criteria:

          -  Mini-mental state examination (MMSE) &lt; 28

          -  Systolic blood pressure (SBP) &gt;139 mmHg

          -  Diastolic blood pressure (DBP) &gt; 89 mmHg

          -  Total cholesterol &gt; 6.5 mmol/L
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>50 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Sonia de Pascual-Teresa, PhD</last_name>
    <phone>+34915492300</phone>
    <phone_ext>231309</phone_ext>
    <email>s.depascualteresa@csic.es</email>
  </overall_contact>
  <location>
    <facility>
      <name>Institute of Food Science, Technology and Nutrition (ICTAN), Spanish National Research Council (CISC)</name>
      <address>
        <city>Madrid</city>
        <zip>28040</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sonia de Pascual-Teresa, PhD</last_name>
      <phone>+34915492300</phone>
      <phone_ext>231390</phone_ext>
      <email>s.depascualteresa@csic.es</email>
    </contact>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>April 2020</verification_date>
  <study_first_submitted>March 26, 2020</study_first_submitted>
  <study_first_submitted_qc>April 13, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">April 16, 2020</study_first_posted>
  <last_update_submitted>April 13, 2020</last_update_submitted>
  <last_update_submitted_qc>April 13, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">April 16, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>National Research Council, Spain</investigator_affiliation>
    <investigator_full_name>Spanish National Research Council</investigator_full_name>
    <investigator_title>PhD</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

